Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Interest Expenses (2016 - 2025)

Perspective Therapeutics' Interest Expenses history spans 9 years, with the latest figure at -$73000.0 for Q4 2024.

  • For Q4 2024, Interest Expenses fell 404.17% year-over-year to -$73000.0; the TTM value through Sep 2025 reached -$73000.0, down 150.34%, while the annual FY2024 figure was $48000.0, 41.46% down from the prior year.
  • Interest Expenses for Q4 2024 was -$73000.0 at Perspective Therapeutics, down from $69000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $69000.0 in Q3 2024 and bottomed at -$73000.0 in Q4 2024.